Pronova BioPharma Norge AS v. Par Pharmaceutical Inc.
1:09-cv-00305
Overview
Parties
Movant
Norsk Hydro North America, Inc. Operating Company
Represented By
1 Attorneys ListedHamm Eckard LLP
5030 Anchor Way, Christiansted, VI 00820
Defendant
Counter Defendant
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Pronova BioPharma Norge AS v. Apotex Corp.
Pronova BioPharma Norge AS v. Teva Pharamceuticals USA, Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5502077
Fatty acid composition
|
Filed: 1992-06-23
Issued: 1996-03-26
|
Expired (Term Ended)
Expires: 2012-06-23
|
|
|
US5656667
Fatty acid composition
|
Filed: 1995-06-06
Issued: 1997-08-12
|
Expired (Term Ended)
+1178d PTA
Expires: 2018-08-27
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).